These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33504364)

  • 1. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy.
    Choi YB; Dunn-Meynell AA; Marchese M; Blumberg BM; Gaindh D; Dowling PC; Lu W
    Alzheimers Res Ther; 2021 Jan; 13(1):32. PubMed ID: 33504364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
    Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
    J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse].
    Yoshiyama Y
    Rinsho Shinkeigaku; 2008 Nov; 48(11):910-2. PubMed ID: 19198115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
    Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
    Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy.
    Sun XY; Dong QX; Zhu J; Sun X; Zhang LF; Qiu M; Yu XL; Liu RT
    Curr Alzheimer Res; 2019; 16(8):710-722. PubMed ID: 31368873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
    Hashem J; Hu M; Zhang J; Gao F; Chen C
    Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
    Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
    Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Dunn-Meynell AA; Dowling P; Marchese M; Rodriguez E; Blumberg B; Choi YB; Gaindh D; Lu W
    Front Aging Neurosci; 2019; 11():252. PubMed ID: 31572168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated sarcopenia precedes learning and memory impairments in the P301S mouse model of tauopathies and Alzheimer's disease.
    Longo S; Messi ML; Wang ZM; Meeker W; Delbono O
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1358-1375. PubMed ID: 38646816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
    Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M
    Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
    Brunden KR; Zhang B; Carroll J; Yao Y; Potuzak JS; Hogan AM; Iba M; James MJ; Xie SX; Ballatore C; Smith AB; Lee VM; Trojanowski JQ
    J Neurosci; 2010 Oct; 30(41):13861-6. PubMed ID: 20943926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
    Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
    Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.
    Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB
    JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
    Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
    J Alzheimers Dis; 2024; 98(2):549-562. PubMed ID: 38393915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.